VIDILI, Gianpaolo
 Distribuzione geografica
Continente #
NA - Nord America 3.881
AS - Asia 2.751
SA - Sud America 1.667
EU - Europa 1.376
AF - Africa 115
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 6
Totale 9.809
Nazione #
US - Stati Uniti d'America 3.763
BR - Brasile 1.484
SG - Singapore 1.237
CN - Cina 664
UA - Ucraina 311
IT - Italia 265
VN - Vietnam 223
HK - Hong Kong 195
DE - Germania 177
FR - Francia 129
SE - Svezia 91
FI - Finlandia 88
GB - Regno Unito 86
RU - Federazione Russa 73
AR - Argentina 65
BD - Bangladesh 55
TR - Turchia 50
IN - India 49
IQ - Iraq 49
CA - Canada 46
MX - Messico 38
ID - Indonesia 32
EC - Ecuador 31
ZA - Sudafrica 31
MA - Marocco 30
UZ - Uzbekistan 28
JP - Giappone 24
PL - Polonia 23
VE - Venezuela 22
CO - Colombia 21
PK - Pakistan 21
AT - Austria 16
BE - Belgio 16
CZ - Repubblica Ceca 16
KR - Corea 15
ES - Italia 14
RO - Romania 14
NL - Olanda 13
AU - Australia 12
KE - Kenya 12
JO - Giordania 11
AE - Emirati Arabi Uniti 10
CL - Cile 10
PY - Paraguay 10
UY - Uruguay 10
CI - Costa d'Avorio 9
LT - Lituania 9
SA - Arabia Saudita 9
AL - Albania 8
AZ - Azerbaigian 8
BO - Bolivia 8
HN - Honduras 7
JM - Giamaica 7
LB - Libano 7
NP - Nepal 7
TN - Tunisia 7
CR - Costa Rica 6
IL - Israele 6
KZ - Kazakistan 6
PE - Perù 6
DO - Repubblica Dominicana 5
EG - Egitto 5
MY - Malesia 5
OM - Oman 5
BN - Brunei Darussalam 4
DZ - Algeria 4
IR - Iran 4
KG - Kirghizistan 4
SN - Senegal 4
BH - Bahrain 3
CH - Svizzera 3
EE - Estonia 3
KW - Kuwait 3
MN - Mongolia 3
NG - Nigeria 3
PA - Panama 3
RS - Serbia 3
XK - ???statistics.table.value.countryCode.XK??? 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
CY - Cipro 2
ET - Etiopia 2
GE - Georgia 2
IE - Irlanda 2
LV - Lettonia 2
NI - Nicaragua 2
PH - Filippine 2
PT - Portogallo 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
TG - Togo 2
AG - Antigua e Barbuda 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BS - Bahamas 1
BT - Bhutan 1
BW - Botswana 1
BY - Bielorussia 1
EU - Europa 1
Totale 9.792
Città #
Dallas 1.282
Singapore 648
Chandler 420
San Jose 324
Ashburn 236
Hong Kong 190
Beijing 183
Jacksonville 178
Princeton 147
São Paulo 107
Lauterbourg 86
Nanjing 82
Ho Chi Minh City 78
Sassari 72
Dearborn 69
Ann Arbor 57
Shanghai 57
Belo Horizonte 53
Hanoi 53
Rio de Janeiro 53
Los Angeles 51
New York 49
Helsinki 48
Wilmington 43
Santa Clara 42
Boardman 30
Moscow 30
Brasília 28
Nanchang 28
Shenyang 26
Tashkent 25
Munich 23
Orem 23
Tokyo 23
Curitiba 22
Woodbridge 21
Nuremberg 20
Porto Alegre 20
Tianjin 20
Frankfurt am Main 19
Warsaw 19
Brooklyn 18
Columbus 18
Atlanta 17
Changsha 17
Council Bluffs 17
Brno 16
Johannesburg 16
Brussels 15
Milan 15
Mountain View 15
Baghdad 14
Houston 14
London 14
Toronto 14
Guangzhou 13
Guayaquil 13
Salvador 13
Seoul 13
Hebei 12
Montreal 12
Nairobi 12
Santo André 12
Stockholm 12
Amman 11
Ankara 11
Campo Grande 11
Chennai 11
Guarulhos 11
Izmir 11
Jiaxing 11
Jinan 11
Ribeirão Preto 11
Rome 11
San Francisco 11
Sarapul 11
The Dalles 11
Vienna 11
Andover 10
Campinas 10
Franca 10
Montevideo 10
Ningbo 10
Ottawa 10
Poplar 10
Recife 10
Abidjan 9
Betim 9
Bogotá 9
Buffalo 9
Casablanca 9
Denver 9
Fortaleza 9
Goiânia 9
Haiphong 9
Juiz de Fora 9
Mauá 9
Quito 9
São José dos Campos 9
Auburn Hills 8
Totale 5.676
Nome #
A functional mammalian target of rapamycin complex 1 signaling is indispensable for c-Myc-driven hepatocarcinogenesis 343
Both de novo synthetized and exogenous fatty acids support the growth of hepatocellular carcinoma cells 185
Bedside ultrasonography (US), Echoscopy and US point of care as a new kind of stethoscope for Internal Medicine Departments: the training program of the Italian Internal Medicine Society (SIMI). 182
Jagged 1 is a major Notch ligand along cholangiocarcinoma development in mice and humans 177
HEPATOCELLULAR CARCINOMA DEVELOPMENT IN A PATIENT WITH HCV INFECTION AFTER ERADICATION WITH DIRECT-ACTING ANTIVIRAL AGENTS 172
Characterization of focal liver lesions with contrast-enhanced ultrasound. 170
INVECCHIAMENTO E SISTEMA ENDOCRINO.LA SOMATOPAUSA, LA ADRENOPAUSA, LE MALATTIE DELLA TIROIDE 170
Evaluation of EZH2 expression in hepatitis B patients 170
The burden of HIV-Associated neurocognitive disorder (HAND) in post-HAART era: Amultidisciplinary review of the literature 159
Targeted therapies in cholangiocarcinoma: emerging evidence from clinical trials 157
Deregulated c-Myc requires a functional HSF1 for experimental and human hepatocarcinogenesis 156
Long-term Clinical Outcomes of Splanchnic Vein Thrombosis Results of an International Registry 148
Clonal populations of hematopoietic cells with paroxysmal nocturnal hemoglobinuria phenotype in patients with splanchnic vein thrombosis. 148
Clinical pattern of celiac disease in a population residing in North Sardinia (Italy) 146
Functionalized multiwalled carbon nanotubes as ultrasound contrast agents 142
Clinical history of cancer-associated splanchnic vein thrombosis 142
A Case of thyroid metastasis from pancreatic cancer: case report and literature review 140
Immune compatible cystine-functionalized superparamagnetic iron oxide nanoparticles as vascular contrast agents in ultrasonography 140
Asymptomatic and symptomatic deep venous thrombosis in hospitalized acutely ill medical patients: risk factors and therapeutic implications. 139
Comparison of 2D Shear Wave Elastography and Transient Elastography in Non-Invasive Evaluation of Liver Fibrosis in Hepatitis C Virus-Related Chronic Liver Disease 136
Inhibition of HSF1 suppresses the growth of hepatocarcinoma cell lines in vitro and AKT-driven hepatocarcinogenesis in mice 131
Clinical presentation, diagnosis, and staging of cholangiocarcinoma 128
Methotrexate therapy is not associated with increased liver stiffness and significant liver fibrosis in rheumatoid arthritis patients: a cross-sectional controlled study with real-time two-dimensional shear wave elastography 128
Fitz-Hugh-Curtis-syndrome mimicking acute cholecystitis: value of new ultrasound findings in the differential diagnosis 127
Antithrombotic treatment of splanchnic vein thrombosis: Results of an international registry 127
Pan-mTOR inhibitor MLN0128 is effective against intrahepatic cholangiocarcinoma in mice 126
Experience of high frequency ultrasound in rare scalp pathology 126
Effect of Probiotic Use on Adverse Events in Adult Patients with Inflammatory Bowel Disease: a retrospective Cohort Study 125
Diagnostic features of real-time contrast-enhanced ultrasound in focal nodular hyperplasia of the liver 120
Focal nodular hyperplasia: new findings at Doppler ultrasonography 118
Characteristics and outcome of anti‐hepatitis D virus positive patients with hepatocellular carcinoma 117
Changes in hepatocellular carcinoma aggressiveness characteristics with an increase in tumor diameter 117
Surgical treatment of chronic multivascular mesenteric ischemia in a patient with antiphospholipid syndrome, abdominal aortic aneurism, and renal cancer: when planning overwhelms complexity Ann Ital Chir. 2016 Dec 20;5. pii: S2239253X16026104. PMID: 27941240 116
Red Cell Distribution Width as a Predictor of Survival in Patients with Hepatocellular Carcinoma 115
Liver Resection vs Nonsurgical Treatments for Patients With Early Multinodular Hepatocellular Carcinoma 114
Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma 112
Comparing Survival of Perihilar Cholangiocarcinoma After R1 Resection Versus Palliative Chemotherapy for Unresected Localized Disease 109
HCC: Identificazione e caratterizzazione ecografica 109
The safety of Sonovue® in abdominal applications: Retrospective analysis of 23188 investigations 109
Functionalized multiwalled carbon nanotubes as ultrasound contrast agents. 108
Low Rate of Intrahospital Deep Venous Thrombosis in Acutely Ill Medical Patients: Results From the AURELIO Study 108
Prevalence and risk factors of moderate to severe hepatic steatosis in patients with rheumatoid arthritis: an ultrasonography cross-sectional case–control study 107
Common Variable Immunodeficiency and Selective IgA Deficiency: Focus on Autoimmune Manifestations and Their Pathogenesis 106
Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry 106
Sorafenib and locoregional treatment in patients with stage B and stage C HCC: Sardinian experience 98
Diagnosis and management of hepatic focal nodular hyperplasia. Journal of Ultrasound 96
Trapianto di fegato 96
Contrast-enhanced ultrasonography features of extramedullary hematopoiesis presenting as a presacral mass: an update of the literature. 96
Safety and efficacy of low-dose fondaparinux (1.5 mg) for the prevention of venous thromboembolism in acutely ill medical patients with renal impairment: the FONDAIR study 95
The impact of vascular and nonvascular findings on the noninvasive diagnosis of small hepatocellular carcinoma based on the EASL and AASLD criteria. 93
Usefulness of ultrasound in the diagnosis of peritoneal tuberculosis 93
Contrast-enhanced ultrasound patterns of hepatocellular adenoma: an Italian multicenter experience 91
Renal hemodynamics and renoprotection 91
Contrast-enhanced ultrasound Liver Imaging Reporting and Data System: Lights and shadows in hepatocellular carcinoma and cholangiocellular carcinoma diagnosis 90
A nomogram-based prognostic model for advanced hepatocellular carcinoma patients treated with sorafenib: A multicenter study 90
Ipertensione portale: aspetti eco-color-Doppler 89
Pathophysiological roles, molecular interactions and clinical implications of long non-coding RNA CCAT2 in human cancer 87
Prothrombotic and inflammatory markers in elderly patients with non-alcoholic hepatic liver disease before and after weight loss: A pilot study 87
Inverse association between glucose‒6‒phosphate dehydrogenase deficiency and hepatocellular carcinoma 87
RASi therapy in the renal haemodynamic in the course of proteinuric chronic nephropathy 87
Surveillance as determinant of long-term survival in non-transplanted hepatocellular carcinoma patients 87
Doppler US and contrast-enhanced perfusional angiosonography in hepatocellular carcinoma 86
Usefulness of ultrasound in the diagnosis of peritoneal tuberculosis 85
Prevalence of peripheral artery disease by abnormal ankle-brachial index in atrial fibrillation: implications for risk and therapy 83
The changing scenario of hepatocellular carcinoma in Italy: an update 82
Microplastics and nanoplastics in cardiovascular disease—a narrative review with worrying links 81
Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002-2033: the ITA.LI.CA database 81
Identification of clinical phenotypes and related survival in patients with large hccs 81
Surveillance for hepatocellular carcinoma with a 3-months interval in “extremely high-risk” patients does not further improve survival 80
Gastrointestinal Ultrasound in Emergency Setting 78
SIUMB guidelines and recommendations for the correct use of ultrasound in the management of patients with focal liver disease 76
Fatty Acid Synthase Promotes Hepatocellular Carcinoma Growth via S-Phase Kinase-Associated Protein 2/p27KIP1 Regulation 75
linical pattern of celiac disease in a population residing in North Sardinia (Italy 75
Comparison of prognostic models in advanced hepatocellular carcinoma patients undergoing Sorafenib: A multicenter study 75
An ultrasound-based approach to jaundice from diagnosis to treatment 75
HSF1 is a prognostic determinant and therapeutic target in intrahepatic cholangiocarcinoma 74
Predictors of non-transplantable recurrence in hepatocellular carcinoma patients treated with frontline liver resection 72
Surgical treatment of hepatocellular carcinoma in the era of COVID-19 pandemic: A comprehensive review of current recommendations 72
Fisica, tecnica e principi di applicazione dell'eco-Doppler in medicina 72
Role of Lung Ultrasound in the Management of Patients with Suspected SARS-CoV-2 Infection in the Emergency Department 71
Monofocal hepatocellular carcinoma: How much does size matter? 70
Non-invasive tools for the prediction of esophageal varices in cirrhosis: Can advanced ultrasound techniques spare endoscopy? 70
SIUMB recommendations for focal pancreatic lesions 69
Transarterial Chemoembolization for Hepatocellular Carcinoma in Clinical Practice: Temporal Trends and Survival Outcomes of an Iterative Treatment 66
Pattern of macrovascular invasion in hepatocellular carcinoma 63
Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment 63
Metabolic dysfunction-associated steatotic liver disease and cardiovascular risk: a comprehensive review 62
Subclinical hyperthyroidism: The cardiovascular point of view 59
Sorafenib and Metronomic Capecitabine in Child-Pugh B patients with advanced HCC: A real-life comparison with best supportive care 58
Infectious Pneumonia and Lung Ultrasound: A Review 55
Time-Varying mHAP-III Is the Most Accurate Predictor of Survival in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization 55
Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programs 53
SIUMB recommendations on the use of ultrasound in neoplastic lesions of the gallbladder and extrahepatic biliary tract 26
High systemic inflammation response index and increased cardiovascular risk and mortality in MASLD: A prospective cohort study 20
null 10
null 5
Totale 9.962
Categoria #
all - tutte 38.789
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.789


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202199 0 0 0 0 0 0 0 0 0 68 22 9
2021/2022352 43 14 2 5 4 4 20 13 24 13 68 142
2022/2023774 80 69 17 131 74 122 0 90 124 8 34 25
2023/2024326 35 14 11 13 38 18 13 43 2 5 25 109
2024/20252.942 43 50 139 90 153 100 176 532 1.044 411 121 83
2025/20264.188 203 1.033 611 625 441 221 593 105 183 173 0 0
Totale 9.962